Volume 23, Number 3—March 2017
Successful Treatment of Human Plague with Oral Ciprofloxacin
|Patient no.||Age, y/sex||Length of illness, d*||Symptoms||Laboratory evidence||Ciprofloxacin dose, mg†|
|1||10/F||7||Fever, left axillary bubo||Bubo, blood cultures positive||250|
|2||52/F||4||Fever, right axillary bubo||Bubo, blood cultures positive||650|
|3||27/F||1||Fever, left inguinal bubo||Bubo, blood cultures positive||750|
|4||36/M||1||Fever, left axillary bubo||Blood culture positive||625|
|5||13/M||6||Fever, chest pain, cough, blood-tinged sputum||Sputum culture positive, blood culture negative||375|
*At time treatment was sought.
†Orally, twice daily; ≈15 mg/kg bodyweight with a maximum of 750 mg.
1Current affiliation: Fort Lewis College, Durango, Colorado, USA.
- Page created: February 17, 2017
- Page last updated: February 17, 2017
- Page last reviewed: February 17, 2017
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)